These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16335904)

  • 1. Impact of the selective serotonin reuptake inhibitor citalopram on insulin sensitivity, leptin and basal cortisol secretion in depressed and non-depressed euglycemic women of reproductive age.
    Kauffman RP; Castracane VD; White DL; Baldock SD; Owens R
    Gynecol Endocrinol; 2005 Sep; 21(3):129-37. PubMed ID: 16335904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression.
    Feighner JP; Overø K
    J Clin Psychiatry; 1999 Dec; 60(12):824-30. PubMed ID: 10665628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients.
    Burke WJ; Gergel I; Bose A
    J Clin Psychiatry; 2002 Apr; 63(4):331-6. PubMed ID: 12000207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].
    Azorin JM; Llorca PM; Despiegel N; Verpillat P
    Encephale; 2004; 30(2):158-66. PubMed ID: 15107719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in plasma and platelet BDNF levels induced by S-citalopram in major depression.
    Serra-Millàs M; López-Vílchez I; Navarro V; Galán AM; Escolar G; Penadés R; Catalán R; Fañanás L; Arias B; Gastó C
    Psychopharmacology (Berl); 2011 Jul; 216(1):1-8. PubMed ID: 21308467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents.
    Wagner KD; Robb AS; Findling RL; Jin J; Gutierrez MM; Heydorn WE
    Am J Psychiatry; 2004 Jun; 161(6):1079-83. PubMed ID: 15169696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5HT1A-mediated stimulation of cortisol release in major depression: use of non-invasive cortisol measurements to predict clinical response.
    Papakostas GI; Chuzi SE; Sousa JL; Fava M
    Eur Arch Psychiatry Clin Neurosci; 2010 Mar; 260(2):175-80. PubMed ID: 19641981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of the response to citalopram and reboxetine in post-stroke depressed patients.
    Rampello L; Chiechio S; Nicoletti G; Alvano A; Vecchio I; Raffaele R; Malaguarnera M
    Psychopharmacology (Berl); 2004 Apr; 173(1-2):73-8. PubMed ID: 14685645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of subsyndromal depressive symptoms in middle-aged and older adults with schizophrenia: effect on functioning.
    Kasckow J; Lanouette N; Patterson T; Fellows I; Golshan S; Solorzano E; Zisook S
    Int J Geriatr Psychiatry; 2010 Feb; 25(2):183-90. PubMed ID: 19711335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citalopram plus low-dose pipamperone versus citalopram plus placebo in patients with major depressive disorder: an 8-week, double-blind, randomized study on magnitude and timing of clinical response.
    Wade AG; Crawford GM; Nemeroff CB; Schatzberg AF; Schlaepfer T; McConnachie A; Haazen L; Buntinx E
    Psychol Med; 2011 Oct; 41(10):2089-97. PubMed ID: 21349239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severity of depression and response to antidepressants: GENPOD randomised controlled trial.
    Wiles NJ; Mulligan J; Peters TJ; Cowen PJ; Mason V; Nutt D; Sharp D; Tallon D; Thomas L; O'Donovan MC; Lewis G
    Br J Psychiatry; 2012 Feb; 200(2):130-6. PubMed ID: 22194183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care.
    Lepola UM; Loft H; Reines EH
    Int Clin Psychopharmacol; 2003 Jul; 18(4):211-7. PubMed ID: 12817155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SSRI, citalopram, improves bradykinesia in patients with Parkinson's disease treated with L-dopa.
    Rampello L; Chiechio S; Raffaele R; Vecchio I; Nicoletti F
    Clin Neuropharmacol; 2002; 25(1):21-4. PubMed ID: 11852292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of abdominally obese men with a serotonin reuptake inhibitor: a pilot study.
    Ljung T; Ahlberg AC; Holm G; Friberg P; Andersson B; Eriksson E; Björntorp P
    J Intern Med; 2001 Sep; 250(3):219-24. PubMed ID: 11555126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Citalopram treatment of fluoxetine nonresponders.
    Thase ME; Feighner JP; Lydiard RB
    J Clin Psychiatry; 2001 Sep; 62(9):683-7. PubMed ID: 11681763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous antidepressant treatment: focus on citalopram.
    Kasper S; Müller-Spahn F
    Eur Arch Psychiatry Clin Neurosci; 2002 Jun; 252(3):105-9. PubMed ID: 12192466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of citalopram before ECT: seizure duration and hormone responses.
    Papakostas YG; Markianos M; Zervas IM; Theodoropoulou M; Vaidakis N; Daras M
    J ECT; 2000 Dec; 16(4):356-60. PubMed ID: 11314873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do atypical features affect outcome in depressed outpatients treated with citalopram?
    Stewart JW; McGrath PJ; Fava M; Wisniewski SR; Zisook S; Cook I; Nierenberg AA; Trivedi MH; Balasubramani GK; Warden D; Lesser I; John Rush A
    Int J Neuropsychopharmacol; 2010 Feb; 13(1):15-30. PubMed ID: 19341509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum BDNF levels before treatment predict SSRI response in depression.
    Wolkowitz OM; Wolf J; Shelly W; Rosser R; Burke HM; Lerner GK; Reus VI; Nelson JC; Epel ES; Mellon SH
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1623-30. PubMed ID: 21749907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.